The results demonstrated increased mRNA levels of WFDC2 in both overall lung cancer and lung adenocarcinoma (LUAD) (Figure 1B,C), with no significant difference observed in lung squamous cell carcinoma (LUSC) (Figure 1D). This evidence concerns the gene WFDC2 and lung adenocarcinoma.